	Efficacy and Safety of First-Line Treatment Options for Oncogene Wild-Type Lung Adenocarcinoma With Liver Metastases. Cancer Med Li J, Ge Y, Liu Q, Wei X, Wang J, Wang X, Wang D, Liu J, Sun Y, Gao A. PMID: 42834503 [PubMed - indexed for MEDLINE]
	Multimodal radiopathomics model predicts postoperative metachronous liver metastasis in gastric cancer. Nat Commun Ding P, Yang J, Guo H, Chen S, Liu Y, Han X, Li S, Wu J, Yang L, Wu H, Meng N, Li X, Gu R, Tian Y, Zhang L, Guo Z, Lu L, Yang S, Meng L, Zhao Q. PMID: 42834048 [PubMed - indexed for MEDLINE]
	H19 and the PD-1/PD-L1 Axis in hepatocellular carcinoma and colorectal cancer: emerging evidence, mechanistic links, and therapeutic perspectives. Clin Exp Med Nami MT, EmamiPari F, Farrokhi N, Fattahyan I, Yekkalam M. PMID: 42831944 [PubMed - indexed for MEDLINE]
	Clinical Presentation and Surgical Management of Liver Hemangioma: A Single-center Retrospective-prospective Study of 101 Cases. Prague Med Rep Nikolaev E, Vylcheva M, Kostov D. PMID: 42831603 [PubMed - indexed for MEDLINE]
	Deep learning-based CNN method for fiducial marker detection in kilovoltage X-ray images for liver tumor motion monitoring. Med Phys Kan F, Jin F, Mylonas A, Zwan B, Nguyen T, Moodie T, Hardcastle N, Liu SF, Mason D, Wang T, Lee YY, Keall P, Sengupta C. PMID: 42830534 [PubMed - indexed for MEDLINE]
	Beyond Antibodies: Glypican-3-Targeting Peptides for Precision Hepatocellular Carcinoma Theranostics. J Pept Sci Nagpure NR, Tripathi NM, Verma N, Bandyopadhyay A. PMID: 42830470 [PubMed - indexed for MEDLINE]
	Fibrolamellar Carcinoma in the Molecular Era: From DNAJB1::PRKACA Biology to Precision Therapeutic Strategies. J Gastrointest Cancer Bayda, Ökten . PMID: 42828719 [PubMed - indexed for MEDLINE]
	Pattern-Based P53 Immunohistochemistry Predicts Recurrence in Colorectal Liver Metastases Without Complete Pathologic Response After Neoadjuvant Chemotherapy. Cancer Rep (Hoboken) Ho PTH, Nguyen DD, Hao VDT, Tran GH, Trung LV, Van Hoang T, Nguyen HB. PMID: 42827381 [PubMed - indexed for MEDLINE]
	Sex Differences in Mortality Among Patients With Hepatocellular Carcinoma. JAMA Netw Open Yan T, Yeh ML, Leong J, Toyoda H, Abe H, Jun DW, Roberts L, Tanaka Y, Schwartz M, Hsu YC, Landis C, Vutien P, Uojima H, Honda T, Buti M, Trinh H, Ogawa E, Yasuda S, Tseng CH, Maeda M, Sola E, Suzuki T, Huang CF, Tsai PC, Dai CY, Huang JF, Chuang WL, Cheung R, Yu ML, Nguyen MH. PMID: 42826017 [PubMed - indexed for MEDLINE]
	Interventional Management of Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis: Are There Differences Between East and West? Curr Oncol Rep Yan R, Sun T, Lu J, Teng GJ. PMID: 42825963 [PubMed - indexed for MEDLINE]
	Metabolic dysfunction and GZMK(+) CD8(+) T-cell remodeling in hepatocellular carcinoma: an evidence-stratified, hypothesis-generating review. Front Immunol Zhong Q, Lyu W, Li J, Song Y, Huang Y, Wang C, Ji J. PMID: 42824776 [PubMed - indexed for MEDLINE]
	Immune escape in portal vein tumor thrombus: an intravascular tumor-immune niche framework for hepatocellular carcinoma. Front Immunol Li X, Ma D, Yuan Z, Zhu J, Gao J. PMID: 42819771 [PubMed - indexed for MEDLINE]
	Surgical Resection of Metachronous Liver Metastases in Non-colorectal Non-neuroendocrine Gastrointestinal Cancers: Systematic Review and Meta-analysis. Anticancer Res Cicolani A, Chiarini L, Goglia M, Giancola ML, Gallo G, Nigri G, Petrucciani N, Carrano FM, D'Angelo F, Aurello P. PMID: 42823176 [PubMed - indexed for MEDLINE]
	Prognostic Significance of PET- SUV(max) in Patients Undergoing Resection of Hepatocellular Carcinoma >3 cm: A Retrospective Analysis. Anticancer Res Ishikawa T, Itoh S, Kitamura Y, Iseda N, Yoshiya S, Motomura T, Toshima T, Isoda T, Ishigami K, Yoshizumi T. PMID: 42823174 [PubMed - indexed for MEDLINE]
	Post-hepatectomy-related DIC Predicts Poor Survival After Resection for Colorectal Liver Metastases. Anticancer Res Arizono M, Furukawa K, Tsunematsu M, Yamahata Y, Nakanishi H, Futagawa Y, Matsumoto M, Haruki K, Kobayashi H, Taniai T, Onda S, Iida K, Ikegami T. PMID: 42823165 [PubMed - indexed for MEDLINE]
	Clinical Determinants Influencing First-line Immune Checkpoint Inhibitor Selection for Unresectable Hepatocellular Carcinoma in Japan. Anticancer Res Yoshida K, Kubo I, Kiyomi A, Homma Y, Zhou Q, Imai S, Sugiura M. PMID: 42823164 [PubMed - indexed for MEDLINE]
	Urinary Volatile Organic Compounds as Non-Invasive Biomarkers to Distinguish Hepatocellular Carcinoma from Cirrhosis: A Multicentre Diagnostic Accuracy Study. Sensors (Basel) Hussain Y, Atique A, Bannaga A, Persaud KC, Arasaradnam RP, Tendency Study Group. PMID: 42817452 [PubMed - indexed for MEDLINE]
	Association between the preoperative C-reactive protein-albumin-lymphocyte index and prognosis after hepatic resection for hepatocellular carcinoma. PLoS One Shimagaki T, Maeda A, Harima T, Sakai A, Matono R, Hashimoto N, Yamaguchi S, Konishi K, Hashimoto K, Maeda T. PMID: 42814752 [PubMed - indexed for MEDLINE]
	Prognostic value of Glasgow prognostic score in patients with advanced hepatitis-B virus-related hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy combined with lenvatinib and toripalimab. J Cancer Res Ther Tang R, Tan H, Zhu H, Jiang B, Chen S, Wu Y, Wang Y, Shen L, Fan W. PMID: 42813859 [PubMed - indexed for MEDLINE]
	Hepatocellular carcinoma etiology evolution in an interventional radiology department of a tertiary hospital in China (2009-2023): A 1,233-case analysis. J Cancer Res Ther Guo Y, Lu S, Zhang X, Yin Y, Xue T, Li Z. PMID: 42813857 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 77691

Page 1 of 3885



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy